#United States #Belgrade #Xtant Medical #Companion Spine #Coflex

Xtant Medical Concludes Sale to Companion Spine

On December 1, 2025, Xtant Medical Holdings, Inc. (NYSE American: XTNT) announced the completion of its previously revealed transaction, selling certain non-core assets related to its Coflex® spinal implant line and all the entities associated with Paradigm Spine GmbH, to Companion Spine, LLC. This strategic move took place for an estimated sum of $19.2 million, comprising $11 million in cash and $8.2 million in seller financing through an unsecured promissory note that will mature on January 15, 2026. This decisive action marks an essential step in enhancing operational efficiency and focusing on core capabilities.

Sean Browne, President and CEO of Xtant Medical, emphasized the significance of this transition, stating, "The sale of these businesses to Companion Spine signifies a vital advancement for Xtant, allowing us to intensify our focus on our main biologics sector. We aim to drive innovations beneficial to surgeons and patients alike while achieving improved financial results. Through this transaction and our expected cash flows from operations, we anticipate continuing our operations without relying on external capital. We've reached an important turning point, and we're proud of what we've accomplished."

The sale encompasses the operating contributions of the sold assets and entities, which will be incorporated into the financial results of Xtant Medical until the date of sale. The intention behind utilizing the proceeds from this transaction is to reduce long-term debt and improve cash liquidity for the company, strengthening its financial foundation while pursuing innovation.

About Xtant Medical Holdings, Inc.

Xtant Medical is dedicated to advancing medical technology, with a primary focus on surgical solutions for spinal and orthopedic conditions. Its mission revolves around honoring the gift of donation, ensuring patients can live fulfilled and complete lives. The company is actively involved in the design, development, and commercialization of various orthobiologic solutions, aimed at chronic and surgical wound care, as well as sports medicine markets. The commitment of the Xtant Medical team reflects integrity and dedication to customer service.

The symbols ™ and ® denote trademarks and registered trademarks of Xtant Medical Holdings, Inc. or its affiliates, and are listed as such in the United States and other countries. All other trademarks mentioned within this context remain the property of their respective owners.

Forward-Looking Statements

This communication contains forward-looking statements per the Private Securities Litigation Reform Act of 1995. Such statements are predictive and refer to future conditions, with terms like "intends," "expects," and "will" being indicative of this nature. The company urges caution, as actual results may significantly differ owing to various factors including potential unanticipated benefits and risks related to the transaction and overall operational performance. Investors can consult the company's filings with the SEC for a comprehensive understanding of associated risks and uncertainties.

For more information about Xtant Medical Holdings, Inc., visit www.xtantmedical.com.